The Department of Defense is offering the Breast Cancer Innovator Award to support visionary individuals who have demonstrated creativity, innovative work, and leadership in the field of breast cancer research. This grant provides funding and freedom for individuals to pursue novel, high-risk ideas that could potentially lead to ending breast cancer. Applicants must have a record of creativity, promise for continued innovation, and the ability to challenge current conventions. The award requires the PI to dedicate at least 50% of their professional effort to breast cancer research and incorporate mentoring of junior investigators. Applicants from various disciplines are encouraged as long as they focus on breast cancer research.
Opportunity ID: 253181
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-14-BCRP-INNOV |
| Funding Opportunity Title: | DoD Breast Cancer Innovator Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 28, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 15, 2014 |
| Current Closing Date for Applications: | Aug 15, 2014 |
| Archive Date: | Sep 14, 2014 |
| Estimated Total Program Funding: | $15,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The Innovator Award supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field including, but not limited to, breast cancer. The Innovator Award will provide these individuals with the funding and freedom to pursue their most novel, visionary, high-risk ideas that could ultimately lead to ending breast cancer. Since the intent of the Innovator Award mechanism is to recognize creative and innovative individuals rather than projects, the central feature of the award is the innovative contribution that the Principal Investigator (PI) can make toward ending breast cancer. The PI should have a past record of creativity, promise for continued innovation in future work, and a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention. The PI is also expected to be established in his/her field and have demonstrated success at forming and leading effective partnerships and collaborations. To further the development of innovative individuals and spark the generation of novel ideas,applications are required to incorporate the mentoring of promising junior investigators. Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must maintain a 50% dedication of his/her full-time professional effort during the award period to breast cancer research. This professional effort in breast cancer research can be through a combination of this award and other current support. Individuals from other disciplines who will apply novel concepts to breast cancer are encouraged to submit. The PI is expected to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals. The PIs research team must include two or more breast cancer consumer advocates. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role should be independent of their employment, and they cannot be employees of any of the organizations participating in the application. Their role should be focused on providing objective input on the research and its potential impact for individuals with, or at risk for, breast cancer. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 253181 Full Announcement-1 -> bcrp_fy14 innov pa_gg2.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00194535 | Mar 28, 2014 | Aug 15, 2014 | View |
Package 1
Mandatory forms
253181 RR_SF424_2_0-2.0.pdf
253181 RR_Budget_1_3-1.3.pdf
253181 RR_KeyPersonExpanded_2_0-2.0.pdf
253181 PerformanceSite_2_0-2.0.pdf
Optional forms
253181 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
